Autologous platelet-rich fibrin matrix in the treatment of diabetic foot ulcers: a case series

Diabetic foot ulcers remain a significant challenge in clinical practice, necessitating innovative strategies to improve healing outcomes. This case series investigates the clinical impact of autologous platelet-rich fibrin matrix (PRFM) in the treatment of non-healing diabetic foot ulcers. By meticulously examining five cases, the study reveals compelling outcomes, including substantial reductions in ulcer size and accelerated healing. Patient-specific considerations, along with a focus on adverse events, provide a comprehensive understanding of the impact of PRFM. The case series underscores the promising role of PRFM as a game-changing adjunctive therapy for challenging diabetic foot ulcers, urging further exploration and integration into mainstream clinical practice.